This HTML5 document contains 72 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38193258
rdf:type
wikibase:Item
schema:description
научни чланак wissenschaftlicher Artikel научная статья artigo científico wetenschappelijk artikel vitenskapelig artikkel article scientifique artikull shkencor מאמר מדעי artigo científico scienca artikolo vetenskaplig artikel artículo científico scientific article published on March 2014 artigo científico বৈজ্ঞানিক নিবন্ধ artículu científicu espublizáu en 2014 vedecký článok scientific article published on March 2014 scientific article published on March 2014 artikel ilmiah article científic articolo scientifico vědecký článek videnskabelig artikel bilimsel makale vitskapeleg artikkel articol științific наукова стаття, опублікована в березні 2014 مقالة علمية نشرت في مارس 2014
p:P577
wds:Q38193258-BDD5C085-AE59-4FD0-AF03-93F8187EFA1E
wdt:P577
2014-03-01T00:00:00Z
p:P2093
wds:Q38193258-DE86FC56-3833-4AC2-A071-727D19F7A338 wds:Q38193258-3CF33E5E-C237-4015-87EB-9845014CA15E wds:Q38193258-5A467879-A02F-42B3-BD6D-671BDC73EC4E
wdt:P2093
Joaquim Bellmunt Emiliano Calvo Viktor Grünwald
rdfs:label
Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy
skos:prefLabel
Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy
schema:name
Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy
p:P1476
wds:Q38193258-F115F54A-ACEA-4F23-8B0C-A9E72C9FD805
wdt:P1476
Controversies in renal cell carcinoma: treatment choice after progression on vascular endothelial growth factor-targeted therapy
p:P304
wds:Q38193258-65EDAA78-4679-4251-94A8-C24468CD5A1D
wdt:P304
1321-1329
p:P31
wds:Q38193258-719D8E85-CB2A-4209-8DBD-7C8C74C8136D wds:Q38193258-f9a35e5f-2e8d-4eb7-9389-6d282aabf467
wdt:P31
wd:Q7318358 wd:Q13442814
p:P921
wds:Q38193258-7CB416B2-EF25-4999-9C47-DB8D1F38B905 wds:Q38193258-82B77444-F9D8-4B0B-8898-D9A3603F9C47
wdt:P921
wd:Q111140 wd:Q1164529
p:P698
wds:Q38193258-61FCA15C-4DBA-4553-ADF2-9F7BC166AC79
wdtn:P698
n12:24594299
wdt:P698
24594299
p:P1433
wds:Q38193258-3BE5C6C5-A39F-4421-AA08-A0923FAA98A6
wdt:P1433
wd:Q332260
p:P433
wds:Q38193258-478FA182-4A92-4ADA-85A0-9B586BC3D22F
p:P478
wds:Q38193258-E7FE0EE5-705E-4FC0-A9DC-606A58B405FD
wdt:P433
7
wdt:P478
50
p:P356
wds:Q38193258-CD4784CE-13C1-48B6-B44D-54D86AC7BF0A
wdtn:P356
n9:J.EJCA.2014.02.007
wdt:P356
10.1016/J.EJCA.2014.02.007